Metabonomics Analysis of Plasma Reveals the Lactate to Cholesterol Ratio as an Independent Prognostic Factor of Short-Term Mortality in Acute Heart Failure

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Desmoulin, Franck ^a   Galinier, Michel ^a,b   Trouillet, Charlotte ^a,b   Berry, Matthieu ^a,b   Delmas, Clément ^a,b   Turkieh, Annie ^a   Massabuau, Pierre ^a,b   Taegtmeyer, Heinrich ^c   Smih, Fatima ^a   Rouet, Philippe ^a,b  

^a Université de Toulouse   (France)

^b CHU RANGUEIL   (France)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; LACTIC ACID;

ACUTE HEART FAILURE; ADULT; AGED; ANALYTICAL PARAMETERS; APACHE; ARTICLE; CARDIOGENIC SHOCK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; FEMALE; HUMAN; LACTATE BLOOD LEVEL; LACTATE TO CHOLESTEROL RATIO; MAJOR CLINICAL STUDY; MALE; METABONOMICS; MORTALITY; PROGNOSIS; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SPECTROMETER; SURVIVAL; VALIDATION STUDY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CHOLESTEROL; COHORT STUDIES; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; ROC CURVE;

EID: 84875742475     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060737     Document Type: Article

References (42)

1. Ham C, York N, Sutch S, Shaw R, (2003) Hospital bed utilisation in the NHS, Kaiser Permanente, and the US Medicare programme: analysis of routine data. BMJ 327: 1257.
2. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, et al. (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29: 2388-2442.
3. Krumholz HM, Chen YT, Wang Y, Vaccarino V, Radford MJ, et al. (2000) Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J 139: 72-77.
4. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, et al. (2003) The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24: 442-463.
5. Daniels LB, Maisel AS, (2007) Natriuretic peptides. J Am Coll Cardiol 50: 2357-2368.
6. Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, et al. (2008) Pro-B-type natriuretic peptide levels in acute decompensated heart failure. J Am Coll Cardiol 51: 1874-1882.
7. van Kimmenade RR, Pinto YM, Bayes-Genis A, Lainchbury JG, Richards AM, et al. (2006) Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure. Am J Cardiol 98: 386-390.
8. Peacock WFt, De Marco T, Fonarow GC, Diercks D, Wynne J, et al. (2008) Cardiac troponin and outcome in acute heart failure. N Engl J Med 358: 2117-2126.
9. Philip-Couderc P, Smih F, Pelat M, Vidal C, Verwaerde P, et al. (2003) Cardiac transcriptome analysis in obesity-related hypertension. Hypertension 41: 414-421.
10. Philip-Couderc P, Pathak A, Smih F, Dambrin C, Harmancey R, et al. (2004) Uncomplicated human obesity is associated with a specific cardiac transcriptome: involvement of the Wnt pathway. Faseb J 18: 1539-1540.
11. Philip-Couderc P, Smih F, Hall JE, Pathak A, Roncalli J, et al. (2004) Kinetic analysis of cardiac transcriptome regulation during chronic high-fat diet in dogs. Physiol Genomics 19: 32-40.
12. Roncalli J, Smih F, Desmoulin F, Dumonteil N, Harmancey R, et al. (2007) NMR and cDNA array analysis prior to heart failure reveals an increase of unsaturated lipids, a glutamine/glutamate ratio decrease and a specific transcriptome adaptation in obese rat heart. J Mol Cell Cardiol 42: 526-539.
13. Trocme C, Marotte H, Baillet A, Pallot-Prades B, Garin J, et al. (2009) Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis. Ann Rheum Dis 68: 1328-1333.
14. Lewis GD, Asnani A, Gerszten RE, (2008) Application of metabolomics to cardiovascular biomarker and pathway discovery. J Am Coll Cardiol 52: 117-123.
15. Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, et al. (2002) Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med 8: 1439-1444.
16. Knaus WA, Draper EA, Wagner DP, Zimmerman JE, (1985) APACHE II: a severity of disease classification system. Crit Care Med 13: 818-829.
17. Tyagi RK, Azrad A, Degani H, Salomon Y, (1996) Simultaneous extraction of cellular lipids and water-soluble metabolites: evaluation by NMR spectroscopy. Magn Reson Med 35: 194-200.
18. Makinen VP, Soininen P, Forsblom C, Parkkonen M, Ingman P, et al. (2006) Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum. Magma 19: 281-296.
19. DeLong ER, DeLong DM, Clarke-Pearson DL, (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837-845.
20. Henning RJ, Weil MH, Weiner F, (1982) Blood lactate as prognostic indicator of survival in patients with acute myocardial infarction. Circ Shock 9: 307-315.
21. Krishna U, Joshi SP, Modh M, (2009) An evaluation of serial blood lactate measurement as an early predictor of shock and its outcome in patients of trauma or sepsis. Indian J Crit Care Med 13: 66-73.
22. Canver CC, (2001) Serum lactates are not predictive of heart failure severity in status I cardiac transplant candidates. J Cardiovasc Surg (Torino) 42: 705-707.
23. Oster P, Muchowski H, Heuck CC, Schlierf G, (1981) The prognostic significance of hypocholesterolemia in hospitalized patients. Klin Wochenschr 59: 857-860.
24. Franzblau A, Criqui MH, (1984) Characteristics of persons with marked hypocholesterolemia. A population-based study. J Chronic Dis 37: 387-395.
25. Sassolas A, Cartier R, (1999) [Hypocholesterolemias: causes and diagnosis]. Ann Biol Clin (Paris) 57: 555-560.
26. Richartz BM, Radovancevic B, Frazier OH, Vaughn WK, Taegtmeyer H, (1998) Low serum cholesterol levels predict high perioperative mortality in patients supported by a left-ventricular assist system. Cardiology 89: 184-188.
27. Horwich TB, Hernandez AF, Dai D, Yancy CW, Fonarow GC, (2008) Cholesterol levels and in-hospital mortality in patients with acute decompensated heart failure. Am Heart J 156: 1170-1176.
28. Vincent JL, Moreno R, (2010) Clinical review: scoring systems in the critically ill. Crit Care 14: 207.
29. Booth FV, Short M, Shorr AF, Arkins N, Bates B, et al. (2005) Application of a population-based severity scoring system to individual patients results in frequent misclassification. Crit Care 9: R522-529.
30. Fellahi JL, Hanouz JL, Le Manach Y, Gue X, Monier E, et al. (2009) Simultaneous measurement of cardiac troponin I, B-type natriuretic peptide, and C-reactive protein for the prediction of long-term cardiac outcome after cardiac surgery. Anesthesiology 111: 250-257.
31. Park S, Cho GY, Kim SG, Hwang YI, Kang HR, et al. (2009) Brain natriuretic peptide levels have diagnostic and prognostic capability for cardio-renal syndrome type 4 in intensive care unit patients. Crit Care 13: R70.
32. Faggiano P, Valle R, Aspromonte N, D'Aloia A, Di Tano G,et al. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification. Int J Cardiol 140: 88-94.
33. Di Somma S, Magrini L, Pittoni V, Marino R, Mastrantuono A, et al. (2010) In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study. Crit Care 14: R116.
34. Noveanu M, Breidthardt T, Potocki M, Reichlin T, Twerenbold R, et al. (2011) Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure. Crit Care 15: R1.
35. Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, et al. (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149: 209-216.
36. Adams KF Jr, Uddin N, Patterson JH, (2008) Clinical predictors of in-hospital mortality in acutely decompensated heart failure-piecing together the outcome puzzle. Congest Heart Fail 14: 127-134.
37. Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, et al. (2010) Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 55: 2062-2076.
38. Peacock WF, Nowak R, Maisel A, Di Somma S, Mockel M, et al. (2009) Acute heart failure mortality using copeptin: Results of the biomarkers in acute heart failure trial. Annals of Emergency Medicine 54: abstract 88.
39. Maisel A, Mueller C, Nowak RM, Peacock WF, Ponikowski P, et al. (2011) Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 58: 1057-1067.
40. Maisel A, Xue Y, Shah K, Mueller C, Nowak R, et al. (2011) Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study. Circ Heart Fail 4: 613-620.
41. Smith WR, Poses RM, McClish DK, Huber EC, Clemo FL, et al. (2002) Prognostic judgments and triage decisions for patients with acute congestive heart failure. Chest 121: 1610-1617.
42. Peterson PN, Rumsfeld JS, Liang L, Albert NM, Hernandez AF, et al. (2010) A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program. Circ Cardiovasc Qual Outcomes 3: 25-32.